Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-09

Clinical Trial Update: Calcium for Prevention of Ovarian Hyperstimulation Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating calcium for prevention of ovarian hyperstimulation syndrome has completed; results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium (Calcium)

Snippet

Sponsor: Cairo University | Conditions: Ovarian Hyperstimulation Syndrome | Phase 3 | Status: COMPLETED